Clinical Trial Update: Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating melphalan and radiation therapy followed by lenalidomide in patients undergoing autologous stem cell transplant for Stage I–III multi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Smoldering Multiple Myeloma

Drugs mentioned

• Lenalidomide (lenalidomide)
• Melphalan (Melphalan)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Refractory Multiple Myeloma, Smoldering Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-03-01